Programma

09:30 - 10:00
Ontvangst en registratie
10:00 - 10:05
Welkom
10:05 - 10:35
Myositis, de nieuwe Nederlandse richtlijn myositis en highlights EULAR 2024
10:35 - 11:05
CAR-T cel therapie voor auto-immuunziektes
11:05 - 11:20
Oral abstract: POS1429 Immune checkpoint inhibitor-mediated polymyalgia rheumatica versus primary polymyalgia rheumatica: comparison of disease characteristics and treatment requirement
11:20 - 11:40
Pauze
11:40 - 12:10
Digitalisering van de reumazorg, Quo vadis?
12:10 - 12:40
Uitkomstgerichte zorg
12:40 - 12:55
Oral abstract: Effectiveness and cost-effectiveness of patient-initiated follow-up supported by asynchronous telemedicine in spondyloarthritis (TeleSpA-study): a pragmatic multicentre randomised controlled trial
12:55 - 13:40
Lunchpauze
13:40 - 14:10
Cardiovasculair risicomanagement in RMDs anno 2024
14:10 - 14:40
Urinezuur: hoe belangrijk is het?
14:40 - 14:55
Oral abstract: Support needs of gout patients and suitability of eHealth for (self-)management of gout
14:55 - 15:15
Pauze
15:15 - 15:45
Difficult to manage axiale spondyloarthritis en artritis psoriatica
15:45 - 16:15
Update van de DMARD opties voor de behandeling van artritis psoriatica
16:15 - 16:30
Oral abstract: POS0524 Exploring the interrelationships of Disease Activity, Illness Perceptions, Coping Strategies, Psychological Wellbeing, Central Sensitization and lifestyle factors in Axial Spondyloarthritis using Structural Equation Modeling
16:30
Afsluiting en einde symposium